From: Impact of diabetes mellitus on epithelial ovarian cancer survival
Ā | Diabetic Patients (nĀ =ā37) | Nondiabetic Patients (nĀ =ā178) | P-value |
---|---|---|---|
Age at diagnosis (year)a | 65.35āĀ±ā(10.13) | 61.30āĀ±ā(8.87) | 0.015 |
Follow-upa | 27.97āĀ±ā(13.00) | 41.01āĀ±ā(14.62) | <ā0.001 |
BMIa | 28.10āĀ±ā(2.25) | 25.47āĀ±ā(1.87) | <ā0.001 |
Paritya | 4.45āĀ±ā(3.06) | 2.05āĀ±ā(2.50) | <ā0.001 |
Neoadjuant chemotherapyb | |||
āYes | 3(8.1) | 10(5.6) | 0.563 |
āNo | 34(91.9) | 168(94.4) | |
Menopausal statusb | |||
āPremenopausal | 10(27) | 83(46.6) | 0.029 |
āPostmenopausal | 27(73) | 95(53.4) | |
Stageb | |||
āI | 1(2.7) | 18(10.1) | 0.047 |
āII | 3(8.1) | 42(23.6) | |
āIII | 30(81.1) | 110(61.8) | |
āIV | 3(8.1) | 8(4.5) | |
Gradeb | |||
ā1 | 10(27) | 107(60.1) | 0.001 |
ā2 | 15(40.5) | 38(21.3) | |
ā3 | 12(32.5) | 33(18.5) | |
Histologyb | |||
āSerous | 26(70.3) | 103(57.9) | 0.482 |
āMucinous | 6(16.2) | 41(23) | |
āEndometrioid | 4(10.8) | 16(9) | |
āClear | 1(2.7) | 17(9.6) | |
āTransitional | 0(0) | 1(0.6) | |
Debulking statusb | |||
āOptimal | 14(37.8) | 139(78.5) | <ā0.001 |
āSuboptimal | 23(62.2) | 37(20.9) | |
āUnknown | 0(0) | 1(0.6) | |
HTN | |||
āYes | 10(27) | 28(15.7) | 0.101 |
āNo | 27(73) | 150(84.3) |